CRDF EBITDA Margin
Cardiff Oncology Inc · EBITDA Margin
CRDF EBITDA Margin
Latest reported-8663.46%period ending
CRDF Quarterly EBITDA Margin (0.00% → -8663.46%)
Quarterly ebitda margin
High-resolution chart · PNG
CRDF ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -8,663.4615% | |
| -29,570.7317% | |
| -2,877.7778% | |
| -8,970% | |
| -11,333.8843% | |
| -12,115.5963% | |
| -7,742.3841% | |
| -7,123.6364% | |
| -7,161.3497% | |
| -4,833.6585% | |
| -5,919.2308% | |
| -6,825.5319% | |
| -10,233.3333% | |
| -13,413.253% | |
| -6,727.3438% | |
| -9,129.0323% | |
| -11,434.0659% | |
| -14,813.5135% | |
| -6,653.3835% | |
| -7,910.4651% | |
| -9,776.4706% | |
| -7,393.0556% | |
| -5,533.477% | |
| -3,123.5294% | |
| -9,272.093% | |
| -5,889.7059% | |
| 394.2307% | |
| -7,900.6443% | |
| -2,969.4072% | |
| -2,367.2728% | |
| -5,129.1897% | |
| -4,019.048% | |
| -3,144.4832% | |
| -4,525.0779% | |
| -1,615.66% | |
| -3,214.5392% | |
| -5,772.1746% | |
| -8,496.4677% | |
| -11,417.5559% | |
| -10,908.1738% | |
| -9,330.1335% | |
| -8,550.2274% | |
| -9,184.8481% | |
| -11,010.3982% | |
| -13,095.494% | |
| -3,764.0647% | |
| -7,925.8607% | |
| -8,613.8691% | |
| -1,734.0278% | |
| -2,889.6109% | |
| -5,919.6255% | |
| -9,949.1978% | |
| -10,700.5469% | |
| -917.4693% | |
| -7,135.2957% | |
| -485.3991% | |
| -3,001.2506% | |
| -3,386.092% | |
| -2,591.5348% | |
| -1,326.5055% | |
| -807.474% | |
| -805.3512% | |
| -542.8571% | |
| -13,000% | |
| -1,750% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |